| Relative IC50 (μM) | Absolute IC50 (μM) | Maximal inhibition (%) | |
| LVO(OiPr) | 13±3 | 19±8 | 81% |
| LTi(OiPr)2 | 3±1 | 5±3 | 87% |
| H2L | - | - | 47% |
| Cisplatin | 14±5 | 13±6 | 91% |
| Relative IC50 (μM) | Absolute IC50 (μM) | Maximal inhibition (%) | |
| LVO(OiPr) | 13±3 | 19±8 | 81% |
| LTi(OiPr)2 | 3±1 | 5±3 | 87% |
| H2L | - | - | 47% |
| Cisplatin | 14±5 | 13±6 | 91% |